NAV
₹15.8390
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +17.72%
- 3Y
- —
- 5Y
- —
- Since Inception
- +19.57%
SIP returns (XIRR)
- 1Y
- +25.70%
- 3Y
- —
- 5Y
- —
- Since Inception
- +16.84%
Returns calculated from 20 November 2023 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Thinking about Kotak Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Kotak Healthcare Fund - Regular Plan - Growth Option
- 1Sun Pharmaceutical Industries Ltd.14.04%
- 2Jb Chemicals & Pharmaceuticals Ltd.6.63%
- 3Max Healthcare Institute Ltd.6.31%
- 4Divis Laboratories Ltd.5.90%
- 5Fortis Healthcare India Ltd4.84%
- 6Ami Organics Ltd4.60%
- 7Cipla Ltd.4.22%
- 8Park Medi World Limited (Park Hospital)3.79%
- 9Krishna Institute Of Medical3.56%
- 10Apollo Hospitals Enterprise Ltd.3.08%
Investment Objective
Kotak Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Kotak Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Kotak Mahindra Mutual Fund. The fund has been operational for over 2 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations